Disclaimer : This Blog, its owner, creator & contributor is not a research analyst and not responsible for any loss arising out of any information, post or recommendations appearing on this blog. It does not constitute a recommendation to buy or sell. Investment in stock market is subject to risk, resulting in loss of principal capital. Please do your own due diligence before buying stocks and consult your broker and investment advisor.
Thursday, December 25, 2014
Monday, November 17, 2014
Garware Wall Ropes-The Future Of India In Textile Industry
Garware-Wall
Ropes was established in 1976 by the visionary philanthropist late Mr. B. D.
Garware in collaboration with M/s Wall Industries Inc. USA. Subsequently, the
Cambridge educated Mr. Ramesh Garware took over the reins of the company. At
the helm of affairs till end of 2011, he infused dynamism and the culture of
time bound result orientation across the organization. Weaving the core
competencies of the organization to suit the emerging needs of the customers,
he introduced a slew of far-reaching initiatives like capacity expansion,
forward integration of operations, setting up a dedicated netting plant,
launching new and fabricated products etc. His entrepreneurial instinct coupled
with a humane approach has laid the platform for further growth and consolidation
of the organization.
While going through the fundamentals of the company, the only issue I faced, is its sector, due to which it might face some resistance, and which I why, I was hesitant in writing about it in detail. However, with tremendous efficiency of the company and a very strong product portfolio, it doesn't seem that company is going to be affected by the trend in overall sector.
The company is managed by very well known group with good experience.
Speaking of numbers, over the years, it has not been impressive, but they have kept on posting decent growth with the kind of business they are in. Recently, the focus on R&D and technology has increased, which is likely to aid the company in posting better growth in future.
The company has paid good dividend over the years, and in past 2-3 years, they have made a significant attempt in reducing the debt levels, which is a big positive.
The debt as of now, stands around 56 Cr compared to somewhere around 125 Cr in 2012.
On account of such reduction, the debt:equity ratio is very stable at around 0.2
The book value of the company stands at 125 Rs per share.
For the first half of this fiscal, the company has posted a sales growth of 23% and net profit growth of 68%. As per management, they are expecting the sales to continue growing at 15-20% annually. Based on FY'14 numbers, the EPS stood at 11.4, which means the stock is trading at a P/E of 16. However, with good profit growth this year, the company is likely to post annual EPS around 16-20, which means currently, the stock is trading at a P/E of 10, based on expected annual FY'15 numbers. The ratio can't be considered less, when compared with overall industry, however, looking at above data, I think the potential is huge in future, and there is plenty of scope for margin expansion.
Current market capitalization stands at 425 Cr vs sales of 688 Cr and net profit of 27 Cr.
It will be interesting to see, how market will value the company. when the sales, as expected by management, reaches 1000 Cr, and net profit stands somewhere in the range of 50-70 Cr annually.
However, looking at its 52 weeks high-low, it seems the stock is in radar of many investors, as it has almost grown 4 times this year.
One of the bigger problems, with the companies in textile sector, has been extremely high competition, which is something I feel, should not be the problem with Garware Wall Ropes, because of their uniqueness & mastery in products. However, as every one knows, somewhere the sector, always influences the price of company.
I am hopeful
that some of these projects will enter the late stage development, indicating
even better days for the Company. Hence one can buy Garware Wall Ropes Ltd at
CMP 179 for long term.It is listed in both the exchanges.
LINK TO COMPANY WEBSITE : CLICK HERE
DISCLOSURE: IT IS SAFE TO ASSUME THAT I HAVE VESTED INTEREST IN GARWARE WALL ROPES LTD.Saturday, November 15, 2014
HINDUSTAN MEDIA VENTURES LTD- BEST BUY FOR LONG TERM
Promoters are holding about 75 % stake in HMVL and another 15 % by mutual funds and big investors including Azim Premji of Wipro.Company’s balance sheet is strong with negligible debt and robust operating cash flow . In addition to this, about Rs.400 Cr available as Cash or cash equivalents with the company . Company can use this huge amount for growth either through organic or inorganic expansion or reward its stake holders through share buy back ..etc in future . Considering the strong growth in circulation, possibility of increase in advertisement charges going forward , stability in raw material cost and above all a very strong balance sheet ,HMVL remaining as one of the preferred pick from media space and I believe there is lot of value in it and suitable even for law risk investors who are ready to show patience for steady growth.
Hindustan Media Venture ( HMVL) is listed in both exchanges and trading around Rs.187.
DISCLOSURE: IT IS SAFE TO ASSUME THAT I HAVE VESTED INTEREST IN HT MEDIA VENTURE LTD(HMVL).
Friday, September 12, 2014
DR DATSON LAB - BOOK PROFIT
I
have recommended a BUY on Dr DATSON LAB on July 23,2014
@
Rs.10/- ( Click HERE for old posting ).
Today it hits its high and
currently trading @ Rs.17.65/-,
an
appreciation of about 75 % .One can book profit
at current market price.
Sunday, August 10, 2014
Elder Pharmaceuticals ltd. - ONE STOCK TO WATCH
Elder Pharmaceuticals
Ltd is one of the fastest growing pharmaceutical companies in India . The
company's principal activities include the manufacturing and marketing of
prescription pharmaceutical brands, surgical and medical devices. They are
engaged in the manufacture of a wide range of pharmaceutical product through
research and development and also in the manufacturing and marketing of diverse
products through licensing agreements with international pharmaceutical
companies. They are also engaged in the manufacturing of active pharmaceutical
ingredients. Elder Pharmaceuticals Ltd was incorporated on April 2, 1983 in Maharashtra . The company started their commercial
activities in the year 1988. In the year 1989, they commissioned their first
factory in Navi Mumbai. The company was converted into a public limited company
in August 1998. Over the years, the company launched the medicines either
through their own research or through alliances with global companies. The
company entered into strategic alliances with a number of international
pharmaceutical entities for marketing their products in India and
overseas international acquisitions have strengthened and enabled the company
to become a true-global pharmaceutical company.
They made the tie up with Haw Par,Singapore
during the year 1994 and Fujisawa
during the year 1998. During the year 2000-01, the company entered into joint
venture agreement with Stiefel Laboratories Inc. Also they made a tie up with
Paul Hartmann of Germany for
marketing their incotinence and wound healing in India . During the year 2002-03, the
company made a tie up with an American company namely, Blistex Inc, for license
manufacturing and distribution of their Lip Care products. The company entered
into technical/ marketing collaborations with Covex and Ferrer of Spain for
their products for Cognitive disorders, Cerebral strokes and Head injuries,
Tanabe Seiyaku and Fujisawa of Japan for their products for Hypertension and
Heart Failure and TRB Chemeica of Switzerland for their product for
Osteoarthritis. During the same year, the company entered into new joint
venture agreement with the Universal Group of Companies, Nepal for setting up a pharmaceutical
formulations plant in Nepal .
In March 2003, they started their operation in their Bulk Drug plant at
Patalganga. During the year 2004-05, the company acquired an international
brand 'Tobraneg' from Ely Lilly and company of USA at a price of Rs 172.50 lakh.
During the year 2005-06, they commissioned one of their new manufacturing units
at Sela Qui in Uttarakhand, which is equipped to manufacture tablets and
capsules. The company introduced 'Somazina', a neuroprotector during the year.
During the year 2006-07, the company introduced Eldervit ZC, Redirinse, Nedge, Bonviva
and Deviron in the market. Also, they entered with the alliances with Roche of
Switzerland for their product 'Bonivini', Daiwa of Japan for their product
'Biobran' & 'NKCP', Enzymotec of Isreal for their product 'Cardiabeat' and
Almirall of Spain for the product 'Cinitapride'. The company commenced
commercial production of manufacturing of topical formulation in their plant at
Paonta Sahib in Himachal Pradesh during the year. They commissioned a
betalactum plant in Nepal
through a joint venture with Universal Pharmaceuticals. The company also
entered into joint venture with Vincom Pharmaceuticals in Ghana for Oral
Liquid dosages. In January 2007, the company established a wholly owned
subsidiary, called Elder International FZCO in the Jebel Ali Free Trade Zone, Dubai . During the year
2007-08, the company got associated with Cymbiotics of California, USA for
marketing six of their patented products for Diabetes, Chrobnic pain, Skin
Care, etc. and Gnosis of Italy for marketing of 'Sampure'. They formed a wholly
owned subsidiary in Cyprus
by the name Somerta Holdings Co Ltd with a capital of Euro 5000. The company
through their wholly owned subsidiary, Elder International FZCO acquired a 100%
stake in Neutra health PLC, an AIM London Stock Exchange listed company and also
established a wholly owned subsidiary in Bulgaria by the name 'Elder Biomeda
EDA' with the object of acquiring 100% stake in three Biomeda Group companies
for the total investment of Euro 3.12 million. The company was awarded Amity
Corporate Excellence Award for the year 2008 and Frost & Sullivan Market
Leadership Award for 'Shelcal' for the year 2008. They have been named in the
Forbes list of 'Asia 's 200 Best under a
billion' over a period of three years. In November 2008, the company entered
into a deal with Japan 's
Daiwa Pharmaceuticals Co Ltd for manufacturing and marketing of some of their
products in India .
Also,On 7th February 2012 they acquired 100% stake in three Bulgarian pharma companies through their wholly owned Bulgarian subsidiary Elder Biomeda EAD.
LINK TO COMPANY WEBSITE CLICK HERE
DISCLOSURE: IT IS SAFE TO ASSUME THAT I HAVE VESTED
INTEREST IN Elder Pharmaceuticals Ltd.
They made the tie up with Haw Par,
Also,On 7th February 2012 they acquired 100% stake in three Bulgarian pharma companies through their wholly owned Bulgarian subsidiary Elder Biomeda EAD.
I am hopeful that some of these projects will enter
the late stage development, indicating even better days for the Company. Hence
one can buy Elder Pharmaceuticals Ltd at CMP 179 for long term.It is listed in
both the exchanges,scrip code 532322.
LINK TO COMPANY WEBSITE CLICK HERE
DISCLOSURE: IT IS SAFE TO ASSUME THAT I HAVE VESTED
INTEREST IN Elder Pharmaceuticals Ltd.
Tuesday, August 05, 2014
Himalya International Ltd - VALUE BUYING STOCK ?
Himalaya
International Limited is an India-based frozen food company, engaged in
processing mushrooms, baby potatoes and buffalo cheese. The Company is engaged
in manufacturing of mushroom, vegetables, cheese, yogurt, appetizers, snacks
and sweets and daily one tablet. The Company offers three varieties of
Mushrooms: White (Agaricus), Crimini (Italian Brown) and Portobello. It is also
engaged in processing of vegetables and baby potatoes. Himalya International s
work ethics, product quality, innovation, diversification and customer care are
only a few attributes that set the company apart from others and make it an
ideal business partner. Not only does Himalya excel in offering a wide
assortment of products, but also time and again the company has catered to the
needs of its customers through innovative as well as custom fit produce. Its
ideal location, which is the foothills of the mighty Himalayas with freshest of
Air, amidst pristine glacier blue underground water sources and the richest of
soils, make this aspect quite simple really; here anything flourishes. Nature
itself lends a hand to the already unpolluted, green acres. Since 1979 the
company, which started as a small unit, has never looked back. At Himalya,
strategic planning based on predictive customers needs has always set the
momentum for constant diversification within the Specialty Foods.The Company launched
its All Natural chilled and frozen products under its brand Himalya Fresh.
Himalya International Inc. is the Company subsidiary in United States of America ,
engaged in exploring its cheese business in Company. The company, which started
as an export unit has recently decided to enter domestic market to capture the
burgeoning Indian market. For Overseas customers, Himalya provides 24x7 support
from its dedicated Back Office.
One of the India 's foremost diversified
Agribusiness Company Himalya International was formed in 1979. Having the
advantage of India 's
first frozen food company Himalya always tries to satisfy not only the
ravenousness of food but much more than that. Pioneer
in the multiple instances, Himalya has incessantly rejuvenated itself, only to
become more preferred.Nestled in the lap of Himalya we have
the gratification of purest of all the natural resources. Squad of 500 people
all having expertise in agriculture management, plant pathology, storage, farm
mechanization and all with the view of making the food taste you cherish. On
its 25 acre complex Himalaya has four
complementing production units.
If everything is correct and company can materialize
its future plans ,stock may turn as a value buying from current level of just
Rs.13 in next few years.Stock listed only in BSE with scrip code 526899.
Disc : I have vested
interest in "Himalya International Ltd".
Monday, August 04, 2014
Shree Ganesh Jewellery House (I) Ltd - The best bet in Jems & Jewellery sectors .
Shree
Ganesh Jewellery House Ltd is the largest manufacturer and exporter of
hallmarked and handcrafted gold jewellery in India . The company is engaged in
the manufacturing and exporting of handcrafted gold and studded jewellery. Their
products are primarily exported to countries such as the UAE, Singapore , Middle East, Europe , Hongkong and Srilanka.
Design SGJHL Wins 2nd Prize in
Cocktail Category at JAS 2013, Jaipur. On behalf of the company, the award was received by Mr. Rahul Singh-Head-Marketing
and Corporate Communications along with designer-Subal Guin. The ring is made
of 18k Gold and set with Blue tourmaline, Diamonds & Ruby.
Leading celebrity couturier and fashion designer Sabyasachi Mukherjee was an empanelled designer with the company from 2008-2012 and had launched the GAJA SABYASACHI COLLECTION which was targeted at the high end clientele.. The collection is being designed by Sabyasachi Mukherjee and is adorned by leading Bollywood / Tollywood actress like Aishwarya Rai Bachchan in Guzaarish, Rani Mukherjeeand, Vidya Balan. Other bollywood actors like Juhi Chawla, Kiron Kher and Bengali actors like Rituparna Sengupta, Swastika, Subhasree and Koel Mullick etc have also been adorned with jewellery from GAJA.
The company will continue to invest in brand building and the company has launched collection specific brands. These collections are targetted at specific consumer groups and cater to different price points and interests.
The brands have an organic growth strategy and will expand through franchisee and distributorship network.
The company regularly participates in Trade Fairs and Exhibitions to promote and market its brands and products.
Company came out with an IPO in 2010 @ Rs.260 and its current book value is over Rs.118.Stock is currently trading around Rs.30 .Recommending a STRONG BUY at current market price of for long term investors.Stock traded in NSE under symbol 'SGJHL' and in BSE with scrip code 533180.
Leading celebrity couturier and fashion designer Sabyasachi Mukherjee was an empanelled designer with the company from 2008-2012 and had launched the GAJA SABYASACHI COLLECTION which was targeted at the high end clientele.. The collection is being designed by Sabyasachi Mukherjee and is adorned by leading Bollywood / Tollywood actress like Aishwarya Rai Bachchan in Guzaarish, Rani Mukherjeeand, Vidya Balan. Other bollywood actors like Juhi Chawla, Kiron Kher and Bengali actors like Rituparna Sengupta, Swastika, Subhasree and Koel Mullick etc have also been adorned with jewellery from GAJA.
The company will continue to invest in brand building and the company has launched collection specific brands. These collections are targetted at specific consumer groups and cater to different price points and interests.
The brands have an organic growth strategy and will expand through franchisee and distributorship network.
The company regularly participates in Trade Fairs and Exhibitions to promote and market its brands and products.
Disc : It is safe to assume that I have vested interest in "
Shree Ganesh Jewellery House (I) Ltd
".
Friday, July 25, 2014
WeP Soltions Ltd. - Buy For Long Term
WIPRO in 2000 to operate as a
separate company with focus on IT peripherals such
as printers, UPS and networking products, has now given birth to another IT services and solutions firm. As part of its corporate
restructuring plans, the company has demerged its IT services business into a
separate company with primary focus on enterprise security, managed printing
solutions and technology distribution Known as WeP Solutions Ltd., the new
company was legally-separated from WeP Peripherals in March 2008.
WeP Solutions ltd is a leading computer & internet peripherals company inIndia with
annual sales of USD 64 million. Wep commenced operations in 1986 as a
peripherals division of WIPRO LTD, one of the largest it companies in
India
and has become independent legal entity in year 2000. WEP Solutions ltd is one
of the largest employee owned company in the country and has a track record of
uninterrupted growth for the last 18years. WEP is know for its quality with six
sigma initiative and ISO 9000 standards of certifications for its product
development, manufacturing, marketing and support and its unique 30 day money
back offer. Manufacturing facility: Wep has three state-of-the art
manufacturing facilities one at Mysore producing over 120,000 dot matrix
printers per annum, another at Hyderabad producing over 200,000 products and
third manufacturing facility was started in Himachal Pradesh in northern India
a year back for manufacture dot matrix printers Our manufacturing facilities in
Mysore and Hyderabad are ehtp thru which we also do contract manufacturing and
exports to prestigious customers like seiko precision and triumph adler / Bandermann
for European markets and export our printers to China, srilanka, Dubai, Nepal
and other south east Asian countries. All our three manufacturing facilities
are iso-9000 certified.
WeP Solutions ltd is a leading computer & internet peripherals company in
The main customers of WeP in
Design Services division are Honeywell, Wipro, BEL, Nokia , Texas
Instruments, Motorola, Toshiba, Bandermann, Wincor Nixdorf, Printronix etc..
Financials and Conclusion
On a
consolidated basis ,company’s top line spurted from Rs.0.84 Cr in 2010 to Rs.7.64
Cr in 2014 . Its bottom line is still in loss to profit on an yearly basis .In
last financial year , to write of its entire accumulated loss WeP reduced its
equity capital by half .Promoters are holding 39.26 % stake and other FII’s and WIPRO
LTD together holding another 20 % stake. Because of low floating stock
,liquidity is low in this counter.If you are a risk averse investor and
considering conventional valuation parameters for investment decisions ,it is
not a stock for you .I believe, due to various reasons ,company is at an
inflection point and the better days are just coming.But it is a long term
story and a stock only for those with enough patience.Remember ,this is not a 'multibaggerstocksideas'
but a stock suggestion based on the anticipated future growth of company .WeP
is listed only in BSE & BSE CODE : 532373 and currently trading around Rs.10.
Disc : I have vested
interest in "WeP Solutions Ltd".
Thursday, July 24, 2014
HARYANA CAPFIN LIMITED - EMERGENCE OF A DARK HORSE ?
Haryana Capfin Limited is part of Rs.
4,000 Crore D. P. Jindal Group. The Company is engaged in the business of
Finance/Investing activities. The Company is licensed as a Non Banking
Financing Company by Reserve Bank of India .
Non banking financing Company
play a vital role in the context on Indian Economy. They are indispensable part
in the Indian financial system because they supplement the activities of Banks
in term of deposit mobilization and lending. They play a very important role by
providing finance to activities which are not served by the organized Banking
sector. The related NBFC activities have not been started by the Company in
full flow, the Company has invested in the shares of Maharashtra Seamless
Limited, flagship Company of the group..
Haryana Capfin
Ltd was incorporated in the name and style 'Haryana Engineering Pvt Ltd' on
September 9, 1998. The Company was converted into Haryana Engineering Limited
with effect from February 3, 2006. The name of the Company has been changed to
Haryana Capfin Limited with effect from August 09, 2006. In July 2006, as per
scheme of arrangement, Jindal Drilling and Industries Limited transferred its
entire business, pertaining to the Casinvest division to the company with
effect from April 1, 2005. The company's main activities are investment and
financing.
Its current book value is
over Rs.59.50 .Stock is currently trading around Rs.24.Recommending a "STRONG
BUY" at current market price of for long term investors.Stock traded
in BSE with scrip code 532855.
Disc : It is safe to assume that
I have vested interest in
"Haryana Capfin Limited".
Wednesday, July 23, 2014
Dr. DATSONS LABS ( AANJANEYA LIFECARE LTD) - BETTER DAYS AHEAD ?
Aanjaneya Lifecare Limited, India’s fastest growing Pharmaceutical Group having a proven track record of delivering consistence performances engaged in the manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms along with delivery of CRAMS has its presence in 60 countries in the fiercely competitive domestic Contract Manufacturing Market as well as in International market with a significant leadership market presence in Quinine Salts manufacturer in the world said today Aanjaneya Lifecare Limited, India’s fastest growing Pharmaceutical Group having a proven track record of delivering consistence performances engaged in the manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms along with delivery of CRAMS has its presence in 60 countries in the fiercely competitive domestic Contract Manufacturing Market as well as in International market with a significant leadership market presence in Quinine Salts manufacturer in the world , has acquired 100% stake in Fair Success Hong Kong and Dr. Datsons Labs, United Kingdom on 2013.
Aanjaneya Lifecare Limited, BSE code (533412), a Rs 490 crores, integrated pharmaceutical company engaged in the manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms along with delivery of CRAMS has its presence in 60 countries.
The company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to its credit many achievements.
• It is the world’s third-largest manufacturer of quinine salts and the second-largest in India. Only nine companies globally manufacture quinine salts. Aanjaneya is only the second company to receive WHO prequalification for its anti-malarial APIs and formulations.
• It is one of the most cost-effective quinine manufacturers
• One of the largest codeine quota holders in the pharmaceutical sector
• The only manufacturer of multi- flavored Lozenge medical products in India
• The only company in India to be classified as ethical prescription dosages for diverse therapeutic segments. It is positioned as a global Centre of Excellence in the area of Lozenge manufacture
• The company pioneered the recognition that lozenges represent a stable platform for the delivery of pharmaceutical and nutraceutical ingredients
• Anjaneya’s Nicco Nil lozenge is a first-of-its-kind remedy in the world for smoking de-addition; its Relacs is a first-time lozenge against insomnia in India, and Arecta Plus, a lozenge variant for Viagra, is a first for India.
The company has an expertise in opportunity spotting and innovation. The company’s success has been built on a business model that integrates Research, Innovation and Knowledge. The company has invested in building proprietary Knowledge through research and acquisitions.
Anajaneyas Lifecare’s competence has been validated through patents granted by international and Indian authorities.
Positive:-
- Dr.Datsons Labs Ltd has informed BSE that the Company has successfully completed its obligations towards the FCCB Bond Holders for 40 Million USD. There is no Unpaid Debt by the Company towards Bondholders as on July 17, 2014.
- After FCCB conversion, promoter holding is 10 percentage, fii holding 56.79 and and other corporate bodies holding 23 percentage, so almost 90 percentage of shares with promoters n corporate bodies.. only 10 percentage shares with retail investors
- It Will show good quarterly results in future as large demand for their service and as debt came down.
- Currently more than rs.350 crore Asset in hand
- Book value of stock is above 65.38
- cmp 10.00
- Disc : It is safe to assume that I have vested interest in " Dr. DATSONS LABS ".
Monday, July 21, 2014
"BOMBAY RAYON FASHIONS LTD"- BUY ON DECLINE
BRFL is a vertically integrated textile company, engaged in the manufacture of a wide range of fabrics and garments from state of the art production facilities. Apart from being the largest Shirt manufacturer in India, we have successfully evolved into a multi-fiber manufacturing company producing fabrics such as Cotton, Polyester, Tencel, Modal, Lycra, Wool and various blends.BRFL yarn dyed fabric, printing techniques, finishing, processing, weaving, stitching are a mark of excellence making every piece of fabric perfect. With fabric manufacturing facilities of 100 million meters per annum, garment manufacturing facilities of 60 million pieces per annum, being expanded to 90 million pieces per annum and a strong employee base of around 38,000;BRFL is today one of the most sought after brands in the Indian as well as International fashion markets.
BRFL has expanded its working internationally, with active tie ups, joint ventures and subsidiaries, especially in European region like Netherlands, Italy and UK.
BSE CODE : 532678
Current price Rs : 159.00
Accumulation Below Rs : 160
Target Price Rs : 220++
StopLoss Price Rs : 145
Duration : 6(SIX) MONTHS.
Disc : I have vested interest in "BOMBAY RAYON FASHIONS LTD ".
http://multibaggerstocksidea.blogspot.in/
http://multibaggerstocksidea.blogspot.in/
Saturday, July 12, 2014
Friday, July 11, 2014
SIKA INTERPLANT SYSTEMS-LISTED PLAYERS IN "AERONAUTICS & DEFENSE ARENA".
"SIKA" is a Public Listed ISO 9001 Engineering Company in Projects, Systems, Products and Engineering Services for Aerospace, Space, Marine, Automotive and Core Industries. SIKA has offices in Bangalore CBD and manufacturing facilities on Hosur Road, Bangalore. SIKA has offices at Mumbai, Kochi and representatives in other major Cities. This Company is primarily engaged in the business of manufacturing and rendering of services in engineering products, projects and designs for aeronautics and marine sectors. Company’s niche product and service portfolio is really a good point to note. With the growing Indian market in Aerospace and Defence, India is seen as one of the target business markets for the international Aerospace and Defence industry. In this scenario international Aerospace and defence companies want to gain a competitive edge by outsourcing jobs to Indian industry and also provide Indian customers with MRO support in India.Now SIKA is going for upgradation and expansion of its facilities at Bangalore for Design, Supply, certification and MRO(maintenance, repair and overhaul) for Aerospace and Defence. SIKA has an equity base of 3.4 crore and more than 71.54% of this is held by the promoters itself ,which makes it a low liquid counter. Last year company posted an EPS of Rs.6 and declared a dividend of 6%.Even if the performance in the nine month period of this FY is not encouraging ,Company’s dedicated efforts for expansion and upgradation of its Bangalore facility and ongoing developments in aeronautics and defense sector will bring more business forward.This is a niche unknown company and most of the investors are not familiar with its activities. When this story unfold and if things are moving as per the expectations of the management. At a price of Rs.63/- it is a scrip to watch "SIKA" is a worth buy for medium to long term. & Accumulation Below 45/-.
BSE CODE : 523606 .
http://multibaggerstocksidea.blogspot.in/
BSE CODE : 523606 .
http://multibaggerstocksidea.blogspot.in/
Subscribe to:
Posts (Atom)